Value Chain Definition on the Private Health in Brazil.¶

The private health industry in Brazil is structured around a value chain that encompasses a range of activities, from the initial development and supply of medical goods to the direct provision of healthcare services and their financial management. This chain involves numerous players operating within a regulated environment to serve beneficiaries of private health plans and other private patients. A detailed breakdown of this value chain reveals interconnected steps crucial to the functioning of the sector.

Value Chain outline¶

Identification and description of each step in the value chain.¶

Research and Education: This foundational step involves advancing medical knowledge and training the workforce. In the private sector, this includes private investment in research and development, operation of private healthcare education institutions, and continuous professional development initiatives for healthcare practitioners.
Identification and description of segments for each step of the value chain.
- Medical Research & Development: Focuses on the discovery and development of new drugs, medical technologies, and treatment protocols, often conducted by pharmaceutical and medical device companies or private research institutions.
- Healthcare Professional Training: Encompasses undergraduate and postgraduate programs in medicine, nursing, dentistry, and other health-related fields offered by private educational institutions.
- Continuing Medical Education: Provides ongoing training, specialization, and updates on medical advancements and best practices for healthcare professionals, often organized by professional bodies, hospitals, or specialized training companies.
List of types of players in each segment
- Private research centers.
- R&D divisions of pharmaceutical and medical device companies.
- Private universities and medical schools.
- Private technical schools for healthcare professions.
- Medical associations and societies.
- Companies offering professional development courses and certifications.
Detailed description of the main activities within each segment.
- Medical Research & Development: Conducting clinical trials, drug discovery, development of new medical devices and diagnostic techniques, and publishing research findings.
- Healthcare Professional Training: Designing curricula, delivering lectures and practical sessions, supervising clinical rotations and internships, and evaluating student performance.
- Continuing Medical Education: Organizing workshops, conferences, webinars, and online learning platforms to disseminate new medical information, techniques, and regulatory updates.
List examples of key players with detailed profiles.
- While specific private Brazilian entities solely focused on this step were not extensively detailed in the provided sources, R&D is a core activity for major pharmaceutical and medical device companies operating in Brazil (listed in the Supply step). Private universities with health science programs also play a role in education.
Supply of Health Products and Technology: This step involves the manufacturing, importation, and provision of essential medical goods.
Identification and description of segments for each step of the value chain.
- Pharmaceutical Industry: Production, import, and sale of medicines, vaccines, and other pharmaceutical products.
- Medical Devices Industry: Manufacturing, import, and sale of medical equipment, instruments, implants, and diagnostic technologies.
- Hospital and Clinical Supplies: Production and distribution of consumables, materials, and general supplies used in healthcare facilities.
List of types of players in each segment
- Local pharmaceutical manufacturers.
- Multinational pharmaceutical corporations with operations in Brazil.
- Local medical device manufacturers.
- Multinational medical device corporations with operations in Brazil.
- Manufacturers and distributors of hospital consumables.
- Biotechnology companies.
Detailed description of the main activities within each segment.
- Pharmaceutical Industry: Research, manufacturing of active pharmaceutical ingredients (APIs) and finished products, quality control, packaging, obtaining sanitary registration (ANVISA), and marketing to distributors and healthcare providers.
- Medical Devices Industry: Designing, engineering, manufacturing, assembling, testing, obtaining regulatory approval (ANVISA), and selling medical equipment and devices.
- Hospital and Clinical Supplies: Manufacturing or sourcing a wide range of products such as gloves, syringes, bandages, diagnostic reagents, and other consumables, and supplying them to healthcare facilities.
List examples of key players with detailed profiles.
- Pharmaceutical Companies:
- Grupo NC (includes EMS): A major Brazilian pharmaceutical conglomerate with a strong presence in the domestic market, particularly known for EMS, one of the top companies by units sold. The group leads in sales value to pharmacies.
- Hypera Pharma: Another significant Brazilian pharmaceutical company, focusing on diversifying its portfolio. A key player in over-the-counter medications.
- Eurofarma: A Brazilian pharmaceutical company with a growing market share and operations in several countries in Latin America. Showed strong growth in 2024.
- Pfizer: A major multinational pharmaceutical corporation with a significant presence in Brazil, known for a wide range of medicines and vaccines.
- MSD (Merck Sharp & Dohme): Another leading global pharmaceutical company with substantial operations and sales in the Brazilian market.
- Medical Device Companies:
- Medtronic PLC: A large multinational manufacturer of medical devices, particularly strong in cardiovascular and neurological devices.
- Johnson & Johnson: A global healthcare company with a significant medical devices segment.
- Siemens Healthineers: Part of Siemens AG, focused on medical technology, including imaging, diagnostics, and advanced therapies.
Distribution: This step is responsible for the logistical flow of health products from manufacturers to the points of use.
Identification and description of segments for each step of the value chain.
- Pharmaceutical Distribution: Involves wholesalers, distributors, and retail pharmacies that move pharmaceutical products from manufacturing plants or ports to consumers.
- Medical Device Distribution: Logistics and delivery of medical equipment and devices to hospitals, clinics, and laboratories, often requiring specialized handling and technical support.
- Hospital and Clinical Supply Distribution: Management of the supply chain for a wide variety of consumables and materials needed by healthcare providers.
List of types of players in each segment
- Pharmaceutical wholesale distributors.
- Pharmacy chains.
- Independent pharmacies.
- Medical equipment distributors.
- Specialized healthcare logistics providers.
Detailed description of the main activities within each segment.
- Pharmaceutical Distribution: Purchasing from manufacturers, warehousing, inventory management, order fulfillment, transportation, and delivery to pharmacies and healthcare institutions. Retail pharmacies also perform direct sales and provide basic health services to the public.
- Medical Device Distribution: Managing specialized warehousing, transportation, installation, and maintenance services for medical equipment at healthcare facilities.
- Hospital and Clinical Supply Distribution: Procuring, storing, and delivering a broad range of medical and operational supplies to hospitals, clinics, and laboratories, ensuring timely and efficient replenishment.
List examples of key players with detailed profiles.
- Pharmaceutical Distribution (Wholesale): Companies associated with Abafarma (Associação Brasileira de Distribuidores Farmacêuticos). These distributors play a crucial role in ensuring the availability of medicines across the country.
- Pharmaceutical Distribution (Retail - Pharmacies): Brazil has a vast network of pharmacies. Large pharmacy chains operate numerous точки de venda (points of sale) across the country, alongside independent pharmacies. Specific major pharmacy chains were not detailed in the provided sources.
Financial Intermediation: This step manages the financial aspects of private healthcare, primarily through health plans and insurance.
Identification and description of segments for each step of the value chain.
- Health Plan Operators: Companies (Medicina de Grupo, Cooperativas Médicas, Autogestões, Filantropia) that offer health plans and manage access to a network of providers.
- Health Insurance Companies: Offer health insurance policies, typically involving reimbursement or a contracted network.
- Administradoras de Benefícios: Act as intermediaries in contracting group health plans for affiliated legal entities.
List of types of players in each segment
- Medicina de Grupo companies.
- Seguradoras Especializadas em Saúde.
- Cooperativas Médicas (e.g., Unimed system).
- Autogestão entities.
- Administradoras de Benefícios.
- Entities with Philanthropic status operating health plans.
Detailed description of the main activities within each segment.
- Health Plan Operators/Insurance Companies/Administradoras de Benefícios: Designing and selling health benefit products, enrolling and managing beneficiaries, collecting premiums or contributions, building and managing accredited or proprietary networks of hospitals, clinics, and professionals, authorizing procedures, processing and paying claims, managing financial risk, and ensuring compliance with ANS regulations.
List examples of key players with detailed profiles.
- Hapvida NotreDame Intermédica: One of the largest operators by number of beneficiaries, resulting from a significant merger. Operates an extensive network, often with a focus on proprietary facilities.
- Bradesco Saúde: A major health insurance company linked to a large financial group. Known for its wide national coverage and diverse plan options, including different reimbursement levels.
- SulAmérica Saúde: Another large health insurance company in the Brazilian market, offering a variety of flexible plans and a broad accredited network.
- Amil: A significant health plan operator with a strong presence, particularly in major urban centers. Offers a range of plans with varying coverage and coparticipation options.
- Unimed: A system of medical cooperatives that collectively forms a major part of the supplementary health sector. Unimed entities operate health plans and often have their own service infrastructure.
Healthcare Services: This is where direct medical care and support are provided to patients.
Identification and description of segments for each step of the value chain.
- Hospitals: Provide inpatient care, complex medical and surgical treatments, intensive care, and emergency services.
- Clinics (Medical and Specialty): Offer outpatient consultations with general practitioners and specialists, diagnosis, and minor procedures.
- Diagnostic Services: Include clinical laboratories performing tests on biological samples and imaging centers conducting procedures like X-rays, CT scans, and MRIs.
- Ambulatory Care Centers: Provide a range of outpatient services, potentially including minor surgeries and diagnostic procedures, often integrated within larger health networks or as standalone facilities.
- Therapy and Rehabilitation Centers: Offer specialized treatments such as physiotherapy, occupational therapy, and psychological support.
List of types of players in each segment
- Private general hospitals.
- Private specialized hospitals (e.g., oncology, cardiology).
- Private medical clinics (individual and group practices).
- Polyclinics.
- Clinical laboratories.
- Diagnostic imaging centers.
- Day hospitals and standalone surgical centers.
- Rehabilitation clinics and centers.
Detailed description of the main activities within each segment.
- Hospitals: Patient admission, medical and nursing care, performing surgeries and complex procedures, administering medications, providing intensive care, and managing hospital infrastructure and support services.
- Clinics: Conducting patient history and physical examinations, diagnosing illnesses, prescribing treatments, providing vaccinations, and managing chronic conditions.
- Diagnostic Services: Collecting and processing biological samples, performing laboratory analyses using specialized equipment, conducting imaging examinations, interpreting results, and issuing reports for physicians.
- Ambulatory Care Centers: Providing consultations, diagnostic tests, minor surgical procedures, and follow-up care in an outpatient setting.
- Therapy and Rehabilitation Centers: Assessing patient needs, developing treatment plans, and providing therapeutic interventions to restore function and improve well-being.
List examples of key players with detailed profiles.
- Hospitals: While specific national private hospital chains were not detailed with profiles, major groups like Rede D'Or and hospital assets linked to large operators (Amil, Dasa) are significant players. Prestigious hospitals often part of health plan networks include Hospital Israelita Albert Einstein and Hospital Sírio-Libanês. Brazil had approximately 3,900 private hospitals in late 2024.
- Diagnostic Services (Laboratories):
- Dasa: A leading company in diagnostic medicine in Brazil, operating numerous laboratories and imaging centers under various brands (e.g., Delboni Auriemo, Lavoisier). Offers a comprehensive range of diagnostic tests.
- Grupo Fleury: A major player in the diagnostic sector known for its quality and breadth of services, including clinical analyses and diagnostic imaging.
- Sabin Medicina Diagnóstica: A significant laboratory group with a presence in multiple Brazilian regions, offering clinical analyses, imaging, and vaccination services.
Complimentary Health Services: These are services that complement core medical care, focusing on prevention, well-being, and specific non-medical health needs.
Identification and description of segments for each step of the value chain.
- Dental Care Services: Provision of preventive and restorative dental treatments.
- Preventive Health and Wellness Programs: Initiatives promoting healthy lifestyles, disease prevention, and early detection, often offered by health plans or specialized companies.
- Home Care Services: Providing medical, nursing, and support services to patients in their residences.
- Mental Health Services: Including psychological and psychiatric consultations and therapies.
- Nutrition Services: Offering dietary assessment and personalized nutrition plans.
List of types of players in each segment
- Dental clinics and individual dentists.
- Operators of exclusively dental plans.
- Wellness companies and programs.
- Home care agencies.
- Psychologists and psychiatrists (private practices or clinics).
- Nutritionists (private practices or clinics).
Detailed description of the main activities within each segment.
- Dental Care Services: Routine dental check-ups, cleanings, fillings, extractions, root canals, and cosmetic dentistry.
- Preventive Health and Wellness Programs: Health risk assessments, vaccination campaigns, health coaching, stress management programs, and nutritional counseling.
- Home Care Services: Providing medical treatments, nursing care, assistance with daily living activities, and rehabilitation services in the patient's home.
- Mental Health Services: Conducting psychotherapy, counseling, psychiatric evaluations, and medication management.
- Nutrition Services: Assessing dietary habits, developing meal plans, and providing education on healthy eating for disease management or prevention.
List examples of key players with detailed profiles.
- Major operators of exclusively dental plans are key players in the dental care segment. Some health plan operators also incorporate preventive health and wellness programs into their offerings. Specific major players solely focused on the other complimentary health service segments were not extensively detailed in the provided sources.
Regulation: This overarching horizontal step involves the governmental oversight and control of the private health sector.
Identification and description of segments for each step of the value chain.
- Normative and Regulatory Activities: Development and issuance of rules, resolutions, and guidelines governing the operation of health plans, service providers, and health products.
- Supervision and Enforcement: Monitoring compliance with regulations, conducting inspections, investigating complaints, and applying penalties for violations.
List of types of players in each segment
- Agência Nacional de Saúde Suplementar (ANS).
- Ministério da Saúde.
- Agência Nacional de Vigilância Sanitária (ANVISA).
- Consumer defense organizations.
- Judiciary system.
Detailed description of the main activities within each segment.
- Normative and Regulatory Activities: Defining minimum coverage requirements for health plans (Rol de Procedimentos), establishing rules for pricing adjustments, setting standards for provider accreditation, and regulating the financial stability of operators.
- Supervision and Enforcement: Monitoring the quality of services provided, investigating complaints from beneficiaries, auditing operators' financial records, and enforcing compliance through warnings, fines, and other legal measures.
List examples of key players with detailed profiles.
- Agência Nacional de Saúde Suplementar (ANS): The primary regulatory body for the supplementary health sector in Brazil. It is responsible for regulating, controlling, and inspecting health plan operators and ensuring consumer rights are protected. The ANS defines the rules and procedures that govern the relationship between operators, providers, and beneficiaries.

Show estimates of volumes and sizes of each step in the value chain.¶

Supply of Health Products and Technology:
- Pharmaceuticals: The retail pharmaceutical market in Brazil reached R$ 158.4 billion in sales in 2024, with a volume of 8.1 billion units sold. The total Brazilian pharmaceutical market generated US$ 40.5 billion between March 2023 and February 2024, accounting for 47% of the Latin American market.
- Medical Devices: Brazil exported over US$ 1 billion in medical devices in 2024. The medical-hospital segment was the largest contributor to exports, with US$ 804.89 million in 2024. The global medical devices market size was estimated at over US$ 637 billion in 2024.
- Clinical Laboratory Services (Brazil): The market had a gross revenue of R$ 40 billion in 2022, performing 2.2 billion exams.
Financial Intermediation:
- Health Plans (Medical-Hospital): The number of beneficiaries in medical plans was consistently above 51 million throughout 2024, reaching over 52.2 million by December 2024. There were approximately 650-700 operators and over 20 thousand active plans in late 2024.
- Health Plans (Exclusively Dental): The number of beneficiaries in dental plans was around 32.7 to 34.5 million in the latter half of 2024.
Healthcare Services:
- Hospitals: Brazil had over 6,500 hospitals in total in late 2024, with about 60% being private (around 3,900 private hospitals). These hospitals collectively had around 506,000 beds, with 33% (approximately 167,000) being non-SUS beds. There is an estimated deficit of over 10,000 private beds.
- Diagnostic Services (Laboratories - Brazil): See "Clinical Laboratory Services" under Supply, as the market size and volume data often encompass the service provision.
Overall Private Health Sector Size (Brazil): The sector had an annual revenue of R$ 415 billion. The private sector is responsible for approximately 60% of health investment in the country.

Value Chain Summary Table¶

Value Chain Step	Key Segments	Types of Players	Main Activities	Estimated Volume/Size (Brazil, 2024/2025)
Research and Education	Medical Research & Development, Healthcare Professional Training, Continuing Medical Education	Private research centers, Pharma/MedTech R&D, Private universities/schools, Medical associations, Training companies	Conducting research, Designing curricula, Training professionals, Offering continuous development	Data on the specific size of the private sector's contribution is limited.
Supply of Health Products and Technology	Pharmaceutical Industry, Medical Devices Industry, Hospital and Clinical Supplies	Local/Multi Pharma companies, Local/Multi MedTech companies, Hospital supply manufacturers/distributors, Biotech companies	R&D, Manufacturing, Importation, Quality control, Regulatory approval (ANVISA), Marketing, Sales	Pharmaceuticals: R$ 158.4 billion (retail sales 2024), 8.1 billion units (retail volume 2024), R$ 208 billion (total market Mar 2023-Feb 2024). Medical Devices: > US$ 1 billion (exports 2024). Global market size: > US$ 637 billion (2024).
Distribution	Pharmaceutical Distribution (Wholesale/Retail), Medical Device Distribution, Hospital and Clinical Supply Distribution	Pharmaceutical wholesalers, Pharmacy chains/independents, Medical device distributors, Specialized logistics providers	Purchasing, Warehousing, Inventory management, Transportation, Delivery, Sales to providers/consumers	Pharmaceutical Retail: 93.7 thousand pharmacies (2024). Distributors handle ~57% volume and ~56% value in retail.
Financial Intermediation	Health Plan Operators, Health Insurance Companies, Self-Funded Plans, Administradoras de Benefícios	Medicina de Grupo, Seguradoras Especializadas, Cooperativas Médicas, Autogestões, Administradoras de Benefícios, Filantropia	Product design/sales, Beneficiary management, Premium collection, Network management, Authorization/Processing claims, Risk management, ANS compliance	Medical Plans: ~51.0 - 52.2 million beneficiaries (late 2024/early 2025). ~650-700 operators, >20k plans (late 2024). Dental Plans: ~32.7 - 34.5 million beneficiaries (late 2024/early 2025).
Healthcare Services	Hospitals, Clinics, Diagnostic Services (Labs/Imaging), Ambulatory Care, Therapy/Rehabilitation	Private general/specialized hospitals, Private clinics, Clinical laboratories, Diagnostic imaging centers, Ambulatory centers, Rehabilitation centers	In/Outpatient care, Consultations, Diagnosis (lab tests, imaging), Surgeries, Therapies, Emergency services	Hospitals: ~3,900 private hospitals (late 2024), ~167k non-SUS beds. Diagnostic Services (Labs - Brazil): R$ 40 billion revenue, 2.2 billion exams (2022).
Complimentary Health Services	Dental Care, Preventive Health/Wellness, Home Care, Mental Health, Nutrition	Dental clinics/dentists, Dental plan operators, Wellness companies, Home care agencies, Psychologists/Psychiatrists, Nutritionists	Dental treatments, Health promotion/prevention, In-home care, Psychological/Psychiatric consultations, Nutritional counseling	Integrated into other offerings or less specific data for standalone private segments. Beneficiary data for dental plans under Financial Intermediation.
Regulation	Normative and Regulatory Activities, Supervision and Enforcement	ANS, Ministério da Saúde, ANVISA, Consumer defense organizations, Judiciary system	Developing regulations, Setting standards, Monitoring compliance, Conducting inspections, Investigating complaints, Applying penalties	Governs the entire private health sector. Regulatory activities are not typically measured in monetary volume within the value chain flow.

Examples of Main Players¶

Here are profiles of some of the most relevant players across different steps of the private health value chain in Brazil, based on the provided search results:

Financial Intermediation:

Hapvida NotreDame Intermédica: This group is a result of the merger between Hapvida and NotreDame Intermédica, creating one of the largest health plan operators in Brazil by number of beneficiaries. They have a strong focus on verticalization, meaning they own and operate a significant network of hospitals, clinics, and diagnostic centers to provide integrated care to their beneficiaries. This model aims to control costs and improve care coordination.
Bradesco Saúde: As part of the larger Bradesco financial group, Bradesco Saúde is a major health insurance company. It primarily operates through a wide accredited network of hospitals, clinics, and professionals across Brazil, offering a variety of health insurance plans with different levels of coverage and options for reimbursement of expenses. They cater to both corporate and individual clients.

Supply of Health Products and Technology (Pharmaceutical Industry):

Grupo NC (including EMS): A leading Brazilian pharmaceutical group that includes EMS, one of the top pharmaceutical companies in the country based on units sold. The group holds a significant share of the Brazilian pharmaceutical market by revenue. They are involved in the research, development, manufacturing, and commercialization of a broad portfolio of medicines.
Eurofarma: Another prominent Brazilian pharmaceutical company known for its significant growth in the market. Eurofarma is involved in the production and sale of pharmaceuticals in various therapeutic areas and has a presence in several Latin American countries.

Healthcare Services (Diagnostic Services):

Dasa: One of the largest diagnostic medicine companies in Brazil and Latin America. Dasa operates a wide network of laboratories and diagnostic imaging centers under various brands like Delboni Auriemo and Lavoisier. They offer a comprehensive range of clinical analysis and imaging services, playing a crucial role in patient diagnosis and monitoring.
Grupo Fleury: A major player in the Brazilian diagnostic medicine market, known for its high quality and broad scope of services. Grupo Fleury operates laboratories and imaging centers, providing a wide array of diagnostic tests and specialized medical diagnostic services.

Volumes and Sizes¶

Key volume and size estimates for the private health industry in Brazil in 2024 and early 2025 include:

Health Plan Beneficiaries: The medical-hospital segment served between 51.0 million and 52.2 million beneficiaries in 2024, showing an increase compared to the previous year. Exclusively dental plans covered between 32.7 million and 34.5 million beneficiaries in the latter half of 2024, also demonstrating growth.
Health Plan Operators: There were approximately 650-700 operators active in Brazil at the end of 2024.
Pharmaceutical Market: The retail segment alone generated R$ 158.4 billion in sales in 2024, with a volume of 8.1 billion units sold. The total pharmaceutical market in Brazil had a turnover of US$ 40.5 billion (R$ 208 billion) between March 2023 and February 2024.
Medical Device Exports: Brazilian exports of medical devices surpassed US$ 1 billion in 2024.
Private Hospitals: Brazil had roughly 3,900 private hospitals in late 2024, accounting for about 60% of the total hospitals in the country. These private hospitals had approximately 167,000 non-SUS beds, representing 33% of the total hospital beds. There is an estimated deficit of over 10,000 private hospital beds.
Diagnostic Medicine Market (Brazil): This market recorded a gross revenue of R$ 40 billion in 2022, with 2.2 billion exams performed.
Pharmacies and Drugstores: There were 93.7 thousand pharmacies and drugstores operating in Brazil in 2024.
Overall Private Health Sector Revenue: The private health sector in Brazil has an estimated annual revenue of R$ 415 billion. It represents approximately 60% of the total health investment in the country.

Specific market share data for all individual players across every segment was not available in the provided sources. However, in the medical plan market, the top 9 operators accounted for over 41% of beneficiaries as of March 2024, indicating a degree of market concentration among the largest players. Similarly, the top 10 pharmaceutical companies held 48.6% of the sales to pharmacies in 2024.

References¶

ABRE. (2024, August 12). Setor farmacêutico pode crescer quase 10% em 2024, aponta pesquisa.
A Gazeta. (2020, August 14). Confira os laboratórios de análises clínicas vencedores da pesquisa.
Abradilan. (2023, November 27). As 15 maiores indústrias farmacêuticas.
Abradilan. (2025, April 28). Setor farmacêutico cresce 12,7% em 2024, mas reajuste autorizado gera dúvidas e impacto no bolso do consumidor.
Agência Gov. (2024, May 6). Março de 2024: planos de assistência médica somam mais de 51 milhões de usuários.
Agência Nacional de Saúde Suplementar (ANS). (2025, January 3). ANS divulga dados de beneficiários em novembro de 2024. Portal Gov.br.
BenefíciosRH. (2024, May 23). 9 Maiores Operadoras de Planos de Saúde para 2025.
CDPI Pharma. Brasil tem 18 Indústrias Farmacêuticas Bilionárias.
CNseg. (2024, March 14). Planos de saúde alcançam 51 milhões de beneficiários em janeiro de 2024.
FenaSaúde. O que é Saúde Suplementar? | CNseg.
GIFE. (2024, October 28). Saúde Privada no Brasil: estudo inédito do IEPS e Umane analisa setor e suas relações com o SUS nas últimas décadas.
HSM Management. Healthcare: O desafio é alinhar a cadeia de valor.
INAFF. (2025, January 13). Confira o ranking das maiores indústrias farmacêuticas em 2024.
ISTOÉ DINHEIRO. (2025, February 5). Planos de saúde ganham mais de 860 mil clientes em 2024 e atingem recorde de beneficiários.
Investe SP. (2024, May 17). Brasil soma 47% do mercado farmacêutico na América Latina.
Joov. (2024, October 25). Lista de melhores planos de saúde em 2024.
Labtest Diagnóstica. (2023, December 18). Gestão Laboratorial: criando a estratégia para 2024.
Medicina SA. (2024, November 28). O mercado de saúde no Brasil: desafios e potencial de crescimento.
Medi Corretora. (2024, October 7). Melhores planos de saúde 2024: Confira aqui!
Medlife Blog. 5 melhores laboratórios Distrito Federal.
Mordor Intelligence. Mercado de dispositivos médicos- Tamanho, relatório- Visão geral e compartilhamento do setor.
Mordor Intelligence. Mercado de Diagnóstico Clínico- Tamanho, visão geral e tendências do setor.
Mordor Intelligence. Tamanho do mercado de serviços de laboratório clínico, tendências e participação da indústria.
Mordor Intelligence. Tamanho do mercado Dispositivos médicos portáteis e análise de participação - Relatório de Pesquisa da Indústria - Tendências de Crescimento.
Moody's Local. (2025, January 30). Setor de Saúde no Brasil: Estrutura, Fundamentos e Tendências.
NSC Total. (2019, June 21). O mercado de healthcare no Brasil.
Planalto. Lei nº 9.656, de 3 de junho de 1998.
Poder360. (2025, March 9). Varejo farmacêutico cresce 11% e movimenta R$ 158,4 bi em 2024.
Previva. (2024, July 1). Quais são as modalidades de operadoras de planos de saúde no Brasil?
Pride Consultoria. Melhores planos de saúde em 2024: Saiba quais são!
ResearchGate. (2021, January 4). Cadeia de valor da saúde: um modelo para o sistema de saúde brasileiro.
Saúde Business. (2024, March 22). Setor de saúde registra crescimento anual de 5,3% no mercado de trabalho.
Sebrae. Painel Setorial Saúde.
Trier Sistemas. (2025, March 6). Vendas do varejo farmacêutico atingem R$ 158,4 bilhões em 2024.
Unilab. Como os melhores laboratórios do Brasil funcionam?
USP Congresso. preços e níveis de complexidade dos serviços praticados por hospitais privados junto à operadoras de.
VEJA. (2025, February 17). Exportações de dispositivos médicos ultrapassam US$ 1 bilhão em 2024.